Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-21-007290
Filing Date
2021-03-31
Accepted
2021-03-31 16:04:28
Documents
1
Period of Report
2021-03-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 18926
  Complete submission text file 0001567619-21-007290.txt   20313
Mailing Address 180 KIMBALL WAY SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 180 KIMBALL WAY SUITE 200 SOUTH SAN FRANCISCO CA 94080 (650)-822-5500
Annexon, Inc. (Issuer) CIK: 0001528115 (see all company filings)

EIN.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ANNEXON, INC. 180 KIMBALL WAY, SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address
Love Douglas (Reporting) CIK: 0001818520 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39402 | Film No.: 21793229